WEP Clinical announces new London office at Chiswick Business Park. WEP Clinical, a global Clinical Research Organization (CRO) supporting biopharmaceutical partners across the full drug development lifecycle, is pleased to announce the opening of its new London office at Chiswick Business Park. The move marks a deliberate step forward for WEP Clinical as the company experiences significant momentum across its phase 1-4 clinical trial management services and reflects a broader commitment to ensuring its people have access to a workspace that matches the quality and ambition of the work they deliver. Chiswick Business Park is one of west London's most respected business destinations, comprising 1.8 million square feet of award-winning office accommodation and a community built around the belief that people do their best work when they enjoy where they work. That philosophy resonates strongly with WEP Clinical's own people-first culture and its focus on collaboration, wellbeing, and shared success. "As WEP Clinical continues to grow, particularly across our clinical trial management offering, it felt like the right moment to ensure our London team has an environment that truly reflects who we are as a company," said Jas Khera, CEO and Founder of WEP Clinical. "Chiswick Park is a genuinely exceptional place to work, and we are excited to bring our team into a space designed for connection, innovation, and the kind of high-quality thinking our partners and their patients depend on." The new office provides modern, flexible workspaces that support cross-functional collaboration and reinforce WEP Clinical's commitment to building a culture where people can thrive. It further strengthens the company's UK presence as WEP continues to expand its global footprint and deepen its partnerships across the biopharmaceutical industry. About WEP Clinical WEP Clinical is a global CRO with expertise in designing, managing, and executing phase 1-4 Clinical Trials, Expanded and Post-Trial Access Programs, and Clinical Trial Home Nursing solutions across multiple therapeutic areas. With a strong focus on proactive project management, scientific integrity, regulatory compliance, and patient-centric execution, WEP supports pharmaceutical and biotech companies in bringing life-changing therapies to market and creating broader treatment access opportunities for patients. Learn more at www.wepclinical.com.

WEP Clinical acquires Siron Clinical. WEP Clinical acquires Netherlands-based CRO Siron Clinical, expanding global Phase I - IV trial delivery capabilities. Morrisville, NC, USA & London, UK - [January 05, 2026] - WEP Clinical (WEP), a full-service contract research organization (CRO), today announced the acquisition of Siron Clinical (Siron), a Netherlands-based European CRO specializing in flexible, high-quality clinical operations for biotech companies. The acquisition expands WEP's global footprint and strengthens its ability to deliver end-to-end Phase I - IV clinical trial solutions across complex, rare, and specialized therapeutic areas. Founded in 2000, Siron is headquartered in the Netherlands, with additional offices in Belgium and Germany, and clinical research professionals based across Europe and the Middle East. The company specializes in clinical operations, including project management, clinical monitoring, quality assurance, and regulatory submissions. Siron has supported more than 120 studies and is recognized for its strong track record in orphan diseases, pediatric research, and medical device trials. "This acquisition represents a significant milestone in the evolution of our CRO services. By combining WEP's global infrastructure with Siron Clinical's deep operational expertise in complex and niche indications, we can offer sponsors seamless support from early-phase development through post-approval research. Our shared culture, values, and commitment to execution excellence make this an ideal strategic fit, and we look forward to accelerating innovation and impact together." "Joining WEP gives our clients access to expanded services and global reach, while preserving the flexible, hands-on approach they value. We share WEP's commitment to quality, transparency, and patient-focused delivery, and together we will provide a more robust and scalable solution for biotech sponsors worldwide." Siron will be integrated into WEP's Clinical Trials division, enhancing WEP's existing capabilities across trial design, regulatory strategy, start-up, patient recruitment, study execution, and close-out. Clients will benefit from a larger pool of experienced CRAs, project managers, and operational leaders, alongside WEP's broader treatment access and commercialization offerings. WEP Clinical is a global Clinical Research Organization with expertise in designing, managing, and executing clinical trials across multiple therapeutic areas. With a strong focus on proactive project management, scientific integrity, regulatory compliance, and patient-centric execution, WEP supports pharmaceutical and biotech companies in bringing life-changing therapies to market efficiently and safely. Siron Clinical is a European CRO providing flexible and scalable clinical operations expertise for biotech organizations. With more than two decades of experience executing complex clinical trials, Siron delivers localized insight, hands-on support, and adaptive solutions across the clinical development journey.